Don't Ignore This Chart!

Biotech Is Broadening As An Arrowhead (ARWR) Soars

Greg Schnell

Greg Schnell

Chief Technical Analyst, Osprey Strategic

Biotech has been moving up recently as a part of this bullish trend. XBI is one of the many Biotech ETF's. The SCTR breakout is nice to see and the ETF has formed a nice up-trending channel.


As more Biotechs participate, there are some fresh breakouts showing up. Today is a small cap with some nice technical signals. Arrowhead Pharmaceuticals (ARWR) is breaking above a 10-month base. The SCTR has been perking up lately and gave us an early warning things were improving. The Relative Strength is breaking to new highs. With the nice price action breakout, this looks interesting. 

We can see the volume perking up, especially in the zoom box. Biotechs are notoriously volatile and this stock had the huge price/volume shock last year and then went on to build a large base. It looks like whatever they were getting excited about is starting to show up. I'd use the $6.50 level as a hard stop.

Good trading,
Greg Schnell, CMT, MFTA.

 
Greg Schnell
About the author: , CMT, MFTA is Chief Technical Analyst at Osprey Strategic specializing in intermarket and commodities analysis. He is also the co-author of Stock Charts For Dummies (Wiley, 2018). Based in Calgary, Greg is a board member of the Canadian Society of Technical Analysts (CSTA) and the chairman of the CSTA Calgary chapter. He is an active member of both the CMT Association and the International Federation of Technical Analysts (IFTA). Learn More